Key result
Dobutamine infusion successfully enhanced left atrial appendage contractility and cleared spontaneous echo contrast, enabling safe deployment of a WATCHMAN FLX device.
Case Report (n=1)
No
Dobutamine support may facilitate WATCHMAN FLX device deployment in patients with underlying low-flow states and recurrent LAA thrombus.
Answers are grounded in this paper and cite their sources.
May enable WATCHMAN FLX deployment in select low-flow patients; leaves open safety and efficacy questions for prospective study.
We present a rare case of dobutamine-supported WATCHMAN FLX™ device deployment in a medically complex patient prone to recurrent left atrial appendage thrombus and spontaneous echo contrast formation due to underlying low-flow state.
No takes yet. Share an insight, caveat, or question.
Bhattal et al. (2022) conducted a case report in Atrial fibrillation with recurrent left atrial appendage thrombus and spontaneous echo contrast (n=1). Dobutamine infusion was evaluated on Clearance of spontaneous echo contrast and successful WATCHMAN FLX implantation. Dobutamine infusion successfully enhanced left atrial appendage contractility and cleared spontaneous echo contrast, enabling safe deployment of a WATCHMAN FLX device.
Synapse has enriched 10 related papers. Consider them for comparative context: